Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF‐TIMI 48 Trial

Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF‐TIMI 48 Trial

BackgroundDigoxin is widely used in patients with atrial fibrillation despite the lack of randomized controlled trials. Observational studies report conflicting results regarding its association with mortality, perhaps because of residual confounding by the presence of heart failure (HF). Methods an...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Alon Eisen, Christian T. Ruff, Eugene Braunwald, Rose A. Hamershock, Basil S. Lewis, Christian Hassager, Tze‐Fan Chao, Jean Yves Le Heuzey, Michele Mercuri, Howard Rutman, Elliott M. Antman, Robert P. Giugliano
Định dạng: Bài viết
Ngôn ngữ:English
Được phát hành: Wiley 2017-07-01
Loạt:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Những chủ đề:
atrial fibrillation
digoxin
heart failure
mortality
sudden cardiac death
Truy cập trực tuyến:https://www.ahajournals.org/doi/10.1161/JAHA.117.006035

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.117.006035

Những quyển sách tương tự